BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22835434)

  • 21. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
    J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
    Keller JR; Ruscetti SK; Ruscetti FW
    Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of v-Abl transformation by p53 and p19ARF.
    Cong F; Zou X; Hinrichs K; Calame K; Goff SP
    Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
    Karreth FA; DeNicola GM; Winter SP; Tuveson DA
    Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
    Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
    Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming pathways activated by the v-Abl tyrosine kinase.
    Shore SK; Tantravahi RV; Reddy EP
    Oncogene; 2002 Dec; 21(56):8568-76. PubMed ID: 12476303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An enhanced association of RACK1 with Abl in cells transfected with oncogenic ras.
    Huang CC; Liu CH; Chuang NN
    Int J Biochem Cell Biol; 2008; 40(3):423-31. PubMed ID: 17881279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of p53 complements defects in Abelson murine leukemia virus signaling.
    Unnikrishnan I; Rosenberg N
    J Virol; 2003 Jun; 77(11):6208-15. PubMed ID: 12743277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of oncogene expression through intra-population competition.
    Ferreira JP; Wang CL
    Biotechnol J; 2013 Dec; 8(12):1476-84. PubMed ID: 23843261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SH2-containing inositol 5'-phosphatase inhibits transformation of Abelson murine leukemia virus.
    Fessler SP; Rosenberg N; Baughn LB
    J Virol; 2011 Sep; 85(17):9239-42. PubMed ID: 21697469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging applications of flow cytometry in solid tumor biology.
    Chang Q; Hedley D
    Methods; 2012 Jul; 57(3):359-67. PubMed ID: 22503773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response.
    Ahn DG; Sharif T; Chisholm K; Pinto DM; Gujar SA; Lee PW
    Cell Cycle; 2015; 14(14):2301-10. PubMed ID: 25946643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using optogenetics to interrogate the dynamic control of signal transmission by the Ras/Erk module.
    Toettcher JE; Weiner OD; Lim WA
    Cell; 2013 Dec; 155(6):1422-34. PubMed ID: 24315106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CellCycleTRACER accounts for cell cycle and volume in mass cytometry data.
    Rapsomaniki MA; Lun XK; Woerner S; Laumanns M; Bodenmiller B; Martínez MR
    Nat Commun; 2018 Feb; 9(1):632. PubMed ID: 29434325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collective stresses drive competition between monolayers of normal and Ras-transformed cells.
    Moitrier S; Blanch-Mercader C; Garcia S; Sliogeryte K; Martin T; Camonis J; Marcq P; Silberzan P; Bonnet I
    Soft Matter; 2019 Jan; 15(4):537-545. PubMed ID: 30516225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Categorical Analysis of Human T Cell Heterogeneity with One-Dimensional Soli-Expression by Nonlinear Stochastic Embedding.
    Cheng Y; Wong MT; van der Maaten L; Newell EW
    J Immunol; 2016 Jan; 196(2):924-32. PubMed ID: 26667171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.